162 related articles for article (PubMed ID: 11943015)
21. Classification and staging of gynecologic malignancies. ACOG Technical Bulletin Number 155--May 1991 (replaces No. 47, June 1977).
Int J Gynaecol Obstet; 1992 Aug; 38(4):319-23. PubMed ID: 1358693
[No Abstract] [Full Text] [Related]
22. An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus: a study of 54 cases emphasizing the importance of using a panel because of overlap in immunoreactivity for individual antibodies.
Oliva E; Young RH; Amin MB; Clement PB
Am J Surg Pathol; 2002 Apr; 26(4):403-12. PubMed ID: 11914617
[TBL] [Abstract][Full Text] [Related]
23. The immunohistochemical discrimination of endometrioid adenocarcinomas.
Dabbs DJ; Sturtz K; Zaino RJ
Hum Pathol; 1996 Feb; 27(2):172-7. PubMed ID: 8617459
[TBL] [Abstract][Full Text] [Related]
24. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
McCluggage WG; Shah R; Connolly LE; McBride HA
Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach.
Lagendijk JH; Mullink H; van Diest PJ; Meijer GA; Meijer CJ
J Clin Pathol; 1999 Apr; 52(4):283-90. PubMed ID: 10474521
[TBL] [Abstract][Full Text] [Related]
26. SF1 immunohistochemistry is useful in differentiating uterine tumours resembling sex cord-stromal tumours from potential histological mimics.
Stewart CJ; Crook M; Tan A
Pathology; 2016 Aug; 48(5):434-40. PubMed ID: 27311867
[TBL] [Abstract][Full Text] [Related]
27. Concepts in gynaecological pathology: recent advances and their clinical relevance.
Ganesan R; Rollason T
Eur J Surg Oncol; 2006 Sep; 32(7):698-706. PubMed ID: 16765561
[TBL] [Abstract][Full Text] [Related]
28. CD10 expression in the female genital tract: does it have useful diagnostic applications?
Oliva E
Adv Anat Pathol; 2004 Nov; 11(6):310-5. PubMed ID: 15505532
[TBL] [Abstract][Full Text] [Related]
29. HMGA2 is a sensitive but not specific immunohistochemical marker of vulvovaginal aggressive angiomyxoma.
McCluggage WG; Connolly L; McBride HA
Am J Surg Pathol; 2010 Jul; 34(7):1037-42. PubMed ID: 20551826
[TBL] [Abstract][Full Text] [Related]
30. [Multiple cancers in gynecologic oncology].
Schröcksnadel H; Fuith LC; Hetzel H
Geburtshilfe Frauenheilkd; 1988 Oct; 48(10):710-4. PubMed ID: 3234703
[TBL] [Abstract][Full Text] [Related]
31. Recent developments in vulvovaginal pathology.
McCluggage WG
Histopathology; 2009 Jan; 54(2):156-73. PubMed ID: 18637148
[TBL] [Abstract][Full Text] [Related]
32. CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms.
McCluggage WG; Sumathi VP; Maxwell P
Histopathology; 2001 Sep; 39(3):273-8. PubMed ID: 11532038
[TBL] [Abstract][Full Text] [Related]
33. A review and update of morphologically bland vulvovaginal mesenchymal lesions.
McCluggage WG
Int J Gynecol Pathol; 2005 Jan; 24(1):26-38. PubMed ID: 15626915
[TBL] [Abstract][Full Text] [Related]
34. [Tissue cultivation of infected gynecological tumours after sterilization with peracetic acid (author's transl)].
Krafft W; Sprössig M; Müche H; Marzotko F; Preibsch W
Arch Geschwulstforsch; 1974; 43(2):177-81. PubMed ID: 4849998
[No Abstract] [Full Text] [Related]
35. CD10 expression in epithelial tissues and tumors of the gynecologic tract: a useful marker in the diagnosis of mesonephric, trophoblastic, and clear cell tumors.
Ordi J; Romagosa C; Tavassoli FA; Nogales F; Palacin A; Condom E; Torné A; Cardesa A
Am J Surg Pathol; 2003 Feb; 27(2):178-86. PubMed ID: 12548163
[TBL] [Abstract][Full Text] [Related]
36. The immunohistochemical profile of malignant mixed müllerian tumor. Overlap with endometrial adenocarcinoma.
Meis JM; Lawrence WD
Am J Clin Pathol; 1990 Jul; 94(1):1-7. PubMed ID: 1694389
[TBL] [Abstract][Full Text] [Related]
37. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
[TBL] [Abstract][Full Text] [Related]
38. A Detailed Immunohistochemical Analysis of a Large Series of Cervical and Vaginal Gastric-type Adenocarcinomas.
Carleton C; Hoang L; Sah S; Kiyokawa T; Karamurzin YS; Talia KL; Park KJ; McCluggage WG
Am J Surg Pathol; 2016 May; 40(5):636-44. PubMed ID: 26685087
[TBL] [Abstract][Full Text] [Related]
39. Use of histone deacetylase 8 (HDAC8), a new marker of smooth muscle differentiation, in the classification of mesenchymal tumors of the uterus.
de Leval L; Waltregny D; Boniver J; Young RH; Castronovo V; Oliva E
Am J Surg Pathol; 2006 Mar; 30(3):319-27. PubMed ID: 16538051
[TBL] [Abstract][Full Text] [Related]
40. Uterine tumour resembling ovarian sex cord tumour is an immunohistochemically polyphenotypic neoplasm which exhibits coexpression of epithelial, myoid and sex cord markers.
Hurrell DP; McCluggage WG
J Clin Pathol; 2007 Oct; 60(10):1148-54. PubMed ID: 17182656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
